240 related articles for article (PubMed ID: 6211978)
1. Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate.
Shane E; Jacobs TP; Siris ES; Steinberg SF; Stoddart K; Canfield RE; Bilezikian JP
Am J Med; 1982 Jun; 72(6):939-44. PubMed ID: 6211978
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.
Jacobs TP; Siris ES; Bilezikian JP; Baquiran DC; Shane E; Canfield RE
Ann Intern Med; 1981 Mar; 94(3):312-6. PubMed ID: 6452846
[TBL] [Abstract][Full Text] [Related]
3. Effects of dichloromethylene diphosphonate on serum and urinary calcium in primary hyperparathyroidism.
Shane E; Baquiran DC; Bilezikian JP
Ann Intern Med; 1981 Jul; 95(1):23-7. PubMed ID: 6264825
[TBL] [Abstract][Full Text] [Related]
4. Dichloromethylene diphosphonate action in hematologic and other malignancies.
Canfield RE; Siris ES; Jacobs TP
Bone; 1987; 8 Suppl 1():S57-62. PubMed ID: 2961356
[TBL] [Abstract][Full Text] [Related]
5. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma.
Paterson AD; Kanis JA; Cameron EC; Douglas DL; Beard DJ; Preston FE; Russell RG
Br J Haematol; 1983 May; 54(1):121-32. PubMed ID: 6221750
[TBL] [Abstract][Full Text] [Related]
6. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.
Chapuy MC; Meunier PJ; Alexandre CM; Vignon EP
J Clin Invest; 1980 May; 65(5):1243-7. PubMed ID: 6444955
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
[TBL] [Abstract][Full Text] [Related]
8. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism.
Elomaa I; Blomqvist C; Porkka L; Holmström T; Laine H
Cancer Treat Rep; 1984 Apr; 68(4):655-7. PubMed ID: 6231989
[TBL] [Abstract][Full Text] [Related]
10. Effects of dichloromethylene diphosphonate in women with breast carcinoma metastatic to the skeleton.
Siris ES; Hyman GA; Canfield RE
Am J Med; 1983 Mar; 74(3):401-6. PubMed ID: 6219577
[TBL] [Abstract][Full Text] [Related]
11. Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease.
Douglas DL; Duckworth T; Russell RG; Kanis JA; Preston CJ; Preston FE; Prenton MA; Woodhead JS
Lancet; 1980 May; 1(8177):1043-7. PubMed ID: 6103389
[TBL] [Abstract][Full Text] [Related]
12. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma.
Siris ES; Sherman WH; Baquiran DC; Schlatterer JP; Osserman EF; Canfield RE
N Engl J Med; 1980 Feb; 302(6):310-5. PubMed ID: 6444241
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.
Jung A
Am J Med; 1982 Feb; 72(2):221-6. PubMed ID: 6460442
[TBL] [Abstract][Full Text] [Related]
14. Treatment of malignant hypercalcaemia with clodronate.
Percival RC; Paterson AD; Yates AJ; Beard DJ; Douglas DL; Neal FE; Russell RG; Kanis JA
Br J Cancer; 1985 May; 51(5):665-9. PubMed ID: 3158326
[TBL] [Abstract][Full Text] [Related]
15. Hypercalcemia in malignancies: treatment with dichloromethylene diphosphonate (Cl2MDP).
Conte N; Di Virgilio R; Roiter I; Caberlotto L
Tumori; 1985 Feb; 71(1):51-4. PubMed ID: 3157251
[TBL] [Abstract][Full Text] [Related]
16. Clodronate in the medical management of hyperparathyroidism.
Hamdy NA; Gray RE; McCloskey E; Galloway J; Rattenbury JM; Brown CB; Kanis JA
Bone; 1987; 8 Suppl 1():S69-77. PubMed ID: 2961358
[TBL] [Abstract][Full Text] [Related]
17. Parenteral diphosphonates for treating malignant hypercalcemia.
Jung A; van Ouwenaller C; Chantraine A; Courvoisier B
Cancer; 1981 Oct; 48(8):1922-5. PubMed ID: 6456809
[TBL] [Abstract][Full Text] [Related]
18. Long term effects of dichloromethylene diphosphonate in Paget's disease of bone.
Delmas PD; Chapuy MC; Vignon E; Charhon S; Briancon D; Alexandre C; Edouard C; Meunier PJ
J Clin Endocrinol Metab; 1982 Apr; 54(4):837-44. PubMed ID: 6460781
[TBL] [Abstract][Full Text] [Related]
19. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
Vega EM; Mautalen CA
Medicina (B Aires); 1991; 51(2):106-10. PubMed ID: 1820495
[TBL] [Abstract][Full Text] [Related]
20. [[Clodronate therapy of hypercalcemia caused by hyperparathyroidism].
Hoffmeyer P; Groebli Y; Spiliopoulos A; Jung A
Schweiz Med Wochenschr; 1982 Jan; 112(4):118-20. PubMed ID: 6461066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
